Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 3 Urinary Bladder Neoplasms 1 Tobacco Use Disorder 1 Sunburn 1 Stress, Psychological 1 Stress Disorders, Post-Traumatic 1 Smoking Cessation 1 Sarcoma 1 Prostatic Hyperplasia 1 Motor Activity 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Digestive System Abnormalities 1 Depression 1 Central Nervous System Neoplasms 1 Anxiety Disorders 1 Alzheimer Disease 1 Acquired Immunodeficiency Syndrome 1

Interventions

Cisplatin 109 Radiotherapy 100 Fluorouracil 90 Paclitaxel 75 Oxaliplatin 63 Docetaxel 56 Carboplatin 55 Irinotecan 41 Esophagectomy 41 Leucovorin 40 Capecitabine 39 Surgical Procedures, Operative 36 Radiation 36 Drug Therapy 31 Neoadjuvant Therapy 25 Chemoradiotherapy 18 Cetuximab 18 S 1 (combination) 17 pembrolizumab 16 camrelizumab 16 Nivolumab 15 Magnetic Resonance Spectroscopy 15 Bevacizumab 15 Blood Specimen Collection 14 Surveys and Questionnaires 12 Radiotherapy, Intensity-Modulated 12 Immunotherapy 11 Epirubicin 11 Biopsy 11 Trastuzumab 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Esophageal Neoplasms × Amyloid × Clear all

NCT02530983 2026-03-30

UDD

Mayo Clinic

Gastrointestinal

Digestive System Abnormalities, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡